Posts Tagged :

Education & Development

2025 Specialty Pharmacy Outcomes Report 70 70 Shields Health Solutions

2025 Specialty Pharmacy Outcomes Report

Specialty pharmacy outcomes, elevated at scale. Download the Full 2025 Specialty Pharmacy Outcomes Report The 5th Annual Shields Specialty Pharmacy Outcomes Report is here. Featuring results from more than 2…

Unlock Your Specialty Pharmacy’s Hidden Value [INFOGRAPHIC] 200 200 Shields Health Solutions

Unlock Your Specialty Pharmacy’s Hidden Value [INFOGRAPHIC]

See how your health system can retain specialty volume, strengthen financial performance, and improve patient outcomes with the right strategy and support. Health systems without fully integrated specialty pharmacy models…

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening 70 70 Shields Health Solutions

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening

Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2025 marked its 21st anniversary — and we couldn’t be…

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies 216 115 Shields Health Solutions

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies

    Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.  

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications 216 115 Shields Health Solutions

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications

    This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.  

Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditation 216 115 Shields Health Solutions

Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditation

    This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.  

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy

  This poster evaluates existing oral oncology medication waste events among patients filling at a health system specialty pharmacy (HSSP).  

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer 216 115 Shields Health Solutions

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer

    This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.  

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

 This poster evaluates the clinical and quality outcomes of a bleeding disorder program in a health system specialty pharmacy.  

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity 216 115 Shields Health Solutions

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity

  This poster assesses the impact of re-training for specialty pharmacy outreach technicians by evaluating improvements in compliance knowledge, technician productivity, and patient enrollment rates.